CoChat

Single-cell multiomic analysis identifies a HOX-PBX gene network regulating the survival of lymphangioleiomyomatosis cells

Open access

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Abstract

Lymphangioleiomyomatosis (LAM) is a rare, progressive lung disease that predominantly affects women. LAM cells carry TSC1/TSC2 mutations, causing mTORC1 hyperactivation and uncontrolled cell growth. mTORC1 inhibitors stabilize lung function; however, sustained efficacy requires long-term administration, and some patients fail to tolerate or respond to therapy. Although the genetic basis of LAM is known, mechanisms underlying LAM pathogenesis remain elusive. We integrated single-cell RNA sequencing and single-nuclei ATAC-seq of LAM lungs to construct a gene regulatory network controlling the transcriptional program of LAM cells. We identified activation of uterine-specific HOX-PBX transcriptional programs in pulmonary LAM CORE cells as regulators of cell survival depending upon HOXD11-PBX1 dimerization. Accordingly, blockage of HOXD11-PBX1 dimerization by HXR9 suppressed LAM cell survival in vitro and in vivo. PBX1 regulated STAT1/3, increased the expression of antiapoptotic genes, and promoted LAM cell survival in vitro. The HOX-PBX gene network provides promising targets for treatment of LAM/TSC mTORC1-hyperactive cancers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/sciadv.adf8549

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. Integrative analysis of single-cell transcriptome and chromatin accessibility in LAM lungs. (A) Left: Uniform manifold approximation and projection (UMAP) visualization of integrated transcriptomic and epigenetic profiling of lymphangioleiomyomatosis (LAM) lung. The integration included 12,361 cells from single-cell RNA sequencing (scRNA-seq) profiling and 10,050 nuclei from multiome and single-nucleus assay for transposase-accessible chromatin (snATAC) profiling. Cells/nuclei were colored by predicted cell types. Middle: UMAP visualization of cells/nuclei colored by data modalities and profiling methods. Right: Dot plot visualization of expression of representative genes differentially expressed in LAMCORE, including known LAM markers [Premelanosome Protein (PMEL), melan-A (MLANA), Vascular Endothelial Growth Factor D (VEGFD), Actin Alpha 2, Smooth Muscle (ACTA2)] and our predicted signature [HOXD11, ESR1, and pre–B cell leukemia homeobox 1 (PBX1)]. iMON, inflammatory monocytes; pMON, patrolling monocytes; IM, interstitial macrophage; AM, alveolar macrophage; AT1, alveolar type 1 cell; VEC, venous endothelial cell; CAP1, capillary cell 1; SVEC, systemic venous endothelial cell; AEC, arterial endothelial cell; VSMC, vascular smooth muscle; AF1, alveolar fibroblast 1; LEC, lymphatic endothelial cell; NK, natural killer; Treg, regulatory T cell. (B) Motifs enriched in the differentially accessible peaks (DAPs) in LAMCORE cells. (C) The expression levels of corresponding transcription factors (TFs) and genes are increased in LAM versus control lung. Pink, predicted signature genes enriched in LAMCORE cells; blue, genes not selectively expressed in LAMCORE, average expression levels (pseudo-bulk) were compared between LAM and control lung. (D) Gene ontology (GO) terms enriched by genes near (<10 kb) DAPs in LAMCORE cells. (E) Heatmap visualization of identified peak-to-gene (P2G) links (y axis), which correlated ATAC accessibility and RNA expression patterns across cells (x axis) in RNA and ATAC profiling of LAM. Labels on the right represent k-means clusters of P2G links. (F) P2G links in genomic regions of HOXA10 (left) and PBX1 (right). Tracks on the top left of each panel showed normalized ATAC accessibility in each cell type. Violin plots on the top right of each panel showed expression patterns of HOXA10 and PBX1 in each cell type. Scores of P2G links represent correlations of ATAC peak accessibility and RNA expression across cell types. bp, base pair.
Fig. 1. Integrative analysis of single-cell transcriptome and chromatin accessibility in LAM lungs. (A) Left: Uniform manifold approximation and projection (UMAP) visualization of integrated transcriptomic and epigenetic profiling of lymphangioleiomyomatosis (LAM) lung. The integration included 12,361 cells from single-cell RNA sequencing (scRNA-seq) profiling and 10,050 nuclei from multiome and single-nucleus assay for transposase-accessible chromatin (snATAC) profiling. Cells/nuclei were colored by predicted cell types. Middle: UMAP visualization of cells/nuclei colored by data modalities and profiling methods. Right: Dot plot visualization of expression of representative genes differentially expressed in LAMCORE, including known LAM markers [Premelanosome Protein (PMEL), melan-A (MLANA), Vascular Endothelial Growth Factor D (VEGFD), Actin Alpha 2, Smooth Muscle (ACTA2)] and our predicted signature [HOXD11, ESR1, and pre–B cell leukemia homeobox 1 (PBX1)]. iMON, inflammatory monocytes; pMON, patrolling monocytes; IM, interstitial macrophage; AM, alveolar macrophage; AT1, alveolar type 1 cell; VEC, venous endothelial cell; CAP1, capillary cell 1; SVEC, systemic venous endothelial cell; AEC, arterial endothelial cell; VSMC, vascular smooth muscle; AF1, alveolar fibroblast 1; LEC, lymphatic endothelial cell; NK, natural killer; Treg, regulatory T cell. (B) Motifs enriched in the differentially accessible peaks (DAPs) in LAMCORE cells. (C) The expression levels of corresponding transcription factors (TFs) and genes are increased in LAM versus control lung. Pink, predicted signature genes enriched in LAMCORE cells; blue, genes not selectively expressed in LAMCORE, average expression levels (pseudo-bulk) were compared between LAM and control lung. (D) Gene ontology (GO) terms enriched by genes near (<10 kb) DAPs in LAMCORE cells. (E) Heatmap visualization of identified peak-to-gene (P2G) links (y axis), which correlated ATAC accessibility and RNA expression patterns across cells (x axis) in RNA and ATAC profiling of LAM. Labels on the right represent k-means clusters of P2G links. (F) P2G links in genomic regions of HOXA10 (left) and PBX1 (right). Tracks on the top left of each panel showed normalized ATAC accessibility in each cell type. Violin plots on the top right of each panel showed expression patterns of HOXA10 and PBX1 in each cell type. Scores of P2G links represent correlations of ATAC peak accessibility and RNA expression across cell types. bp, base pair.CC BY-NC · PubMed Central
Fig. 2. Expression of PBX1 in LAM lung and uterus. (A) Reverse transcription quantitative polymerase chain reaction (RT-qPCR) for PBX1 transcript levels in lung tissues from non-LAM females (n = 3) and LAM (n = 5). (B) Reanalysis of gene expression arrays of LAM lungs (n = 14) and female tumors (n = 38) shows the relative levels of PBX1 transcript. *P < 0.05; ****P < 0.0001, two-tailed unpaired Student’s t test. (C) Formalin-fixed paraffin-embedded (FFPE) lung specimens from two patients with LAM (LAM-1, a to c′; LAM-2, d to f′) were stained with hematoxylin and eosin (H&E) (a, a′, d, and d′), smooth muscle actin (ACTA2) (b, b′, e, and e′), and PBX1 (c, c′, f, and f′). Scale bars, 200 (for a to f) and 50 μm (for a′ to f′). Asterisks in a, a′, d, and d′ indicate LAM nodules. (D) FFPE specimens from a uterine leiomyoma of a patient with LAM were stained with H&E, smooth ACTA2, and PBX1. Scale bars, 20 and 200 μm. DAPI, 4A,6-diamidino-2-phenylindole. (E) FFPE specimens from a sporadic renal angiomyolipoma (AML) were stained with H&E, smooth ACTA2, and PBX1. Scale bars, 20 and 200 μm. (F) Tsc2-null ELT3-V3 or TSC2-addback ELT3-T3 cells (2 × 106) were subcutaneously injected into both flanks of 6- to 8-week-old female CB17/C.B-Igh-1b/IcrTac-Prkdcscid (SCID) mice. Representative images of immunohistochemical staining of PBX1 in xenograft tumors. Scale bars, 20 (for d and h), 50 (for c and g), and 200 μm (for a, b, e, and f). (G) The number of PBX1-positive and PBX1-negative nuclei in F, d and F, h were manually counted. Percentage of PBX1-positive nuclei was calculated. ****P < 0.0001, two-tailed unpaired Student’s t test. (H) Tsc2-null ELT3 (Eker rat uterine leiomyoma-derived) cells (2 × 106) were subcutaneously injected into both flanks of 6- to 8-week-old ovariectomized female CB17/SCID mice supplemented with placebo or 17β-estradiol. Representative images of immunohistochemical staining of PBX1 in xenograft tumors and metastatic lung lesions of ELT3 cells. Scale bars, 20 (right panels) and 50 μm (left panels).
Fig. 2. Expression of PBX1 in LAM lung and uterus. (A) Reverse transcription quantitative polymerase chain reaction (RT-qPCR) for PBX1 transcript levels in lung tissues from non-LAM females (n = 3) and LAM (n = 5). (B) Reanalysis of gene expression arrays of LAM lungs (n = 14) and female tumors (n = 38) shows the relative levels of PBX1 transcript. *P < 0.05; ****P < 0.0001, two-tailed unpaired Student’s t test. (C) Formalin-fixed paraffin-embedded (FFPE) lung specimens from two patients with LAM (LAM-1, a to c′; LAM-2, d to f′) were stained with hematoxylin and eosin (H&E) (a, a′, d, and d′), smooth muscle actin (ACTA2) (b, b′, e, and e′), and PBX1 (c, c′, f, and f′). Scale bars, 200 (for a to f) and 50 μm (for a′ to f′). Asterisks in a, a′, d, and d′ indicate LAM nodules. (D) FFPE specimens from a uterine leiomyoma of a patient with LAM were stained with H&E, smooth ACTA2, and PBX1. Scale bars, 20 and 200 μm. DAPI, 4A,6-diamidino-2-phenylindole. (E) FFPE specimens from a sporadic renal angiomyolipoma (AML) were stained with H&E, smooth ACTA2, and PBX1. Scale bars, 20 and 200 μm. (F) Tsc2-null ELT3-V3 or TSC2-addback ELT3-T3 cells (2 × 106) were subcutaneously injected into both flanks of 6- to 8-week-old female CB17/C.B-Igh-1b/IcrTac-Prkdcscid (SCID) mice. Representative images of immunohistochemical staining of PBX1 in xenograft tumors. Scale bars, 20 (for d and h), 50 (for c and g), and 200 μm (for a, b, e, and f). (G) The number of PBX1-positive and PBX1-negative nuclei in F, d and F, h were manually counted. Percentage of PBX1-positive nuclei was calculated. ****P < 0.0001, two-tailed unpaired Student’s t test. (H) Tsc2-null ELT3 (Eker rat uterine leiomyoma-derived) cells (2 × 106) were subcutaneously injected into both flanks of 6- to 8-week-old ovariectomized female CB17/SCID mice supplemented with placebo or 17β-estradiol. Representative images of immunohistochemical staining of PBX1 in xenograft tumors and metastatic lung lesions of ELT3 cells. Scale bars, 20 (right panels) and 50 μm (left panels).CC BY-NC · PubMed Central
Fig. 3. Integrative analyses of PBX1 ChIP-seq and scRNA-seq identified PBX1-target genes in LAM lung cells. (A) PBX1 targets selectively expressed in LAMCORE cells were identified via integrative analyses of breast cancer PBX1 chromatin immunoprecipitation sequencing (ChIP-seq) (GSE28008) and scRNA-seq of LAM lung (9). (B) Functional enrichment of PBX1 targets in LAMCORE cells. PI3K, phosphatidylinositol 3-kinase; ERK, extracellular signal–regulated kinase; MAPK, mitogen-activated protein kinase; mTOR, mechanistic target of rapamycin complex. (C) 621-101 cells were serum-starved for 24 hours and then incubated with 100 nM E2 for 24 and 48 hours in serum-free Dulbecco’s modified Eagle medium (DMEM) + 1% bovine serum albumin (BSA). Transcript levels of ESR1, PGR, and PBX1 were measured by RT-PCR. Data are means ± SEM. *P < 0.05; **P < 0.01, two-tailed unpaired Student’s t test. n.s., not significant. (D) Nuclear fraction was isolated from ELT3 cells. IP was performed using two HOXD11 antibodies. Mouse immunoglobulin G (IgG) was used as a negative control. Protein levels of PBX1 were assessed by immunoblotting (IB) in HOXD11-IP complex, protein lysate, and nuclear fraction of ELT3 cells. (E) Immunofluorescence staining of PBX1 and HOXD11 in 621-101 cells. Confocal microscopy shows nuclear costaining of PBX1 and HOXD11. (F) Immunofluorescence staining of PBX1 and HOXD11 in LAM lung cells. Confocal microscopy shows nuclear costaining of PBX1 and HOXD11. (G) Genotyping PCR identified wild-type (WT) and PRCre;Tsc2f/f (Tsc2KO) mice (a). Gross examination of mouse uteri at 27 weeks of age. Arrowheads showed uterine tumors and asterisks point to uterine cysts (b). Histopathology showed uterine morphology from a Tsc2KO mouse (c). Immunoblotting analysis of Tsc2 and phosphorylated S6 (phospho-S6) (Ser235/236) in uterine tissues from WT and Tsc2KO mice at 27 weeks of age. β-Actin as a loading control (d). Immunofluorescence staining of PBX1 and HOXD11 in myometrial tumor cells from a Tsc2KO mouse. Confocal microscopy shows nuclear costaining of PBX1 and HOXD11 mouse myometrial tumor cells (e to l). Scale bars, 20 [for (E), (F), and (G, e to l)] and 50 μm [for (G, c)] and 10 mm [for (G, b)].
Fig. 3. Integrative analyses of PBX1 ChIP-seq and scRNA-seq identified PBX1-target genes in LAM lung cells. (A) PBX1 targets selectively expressed in LAMCORE cells were identified via integrative analyses of breast cancer PBX1 chromatin immunoprecipitation sequencing (ChIP-seq) (GSE28008) and scRNA-seq of LAM lung (9). (B) Functional enrichment of PBX1 targets in LAMCORE cells. PI3K, phosphatidylinositol 3-kinase; ERK, extracellular signal–regulated kinase; MAPK, mitogen-activated protein kinase; mTOR, mechanistic target of rapamycin complex. (C) 621-101 cells were serum-starved for 24 hours and then incubated with 100 nM E2 for 24 and 48 hours in serum-free Dulbecco’s modified Eagle medium (DMEM) + 1% bovine serum albumin (BSA). Transcript levels of ESR1, PGR, and PBX1 were measured by RT-PCR. Data are means ± SEM. *P < 0.05; **P < 0.01, two-tailed unpaired Student’s t test. n.s., not significant. (D) Nuclear fraction was isolated from ELT3 cells. IP was performed using two HOXD11 antibodies. Mouse immunoglobulin G (IgG) was used as a negative control. Protein levels of PBX1 were assessed by immunoblotting (IB) in HOXD11-IP complex, protein lysate, and nuclear fraction of ELT3 cells. (E) Immunofluorescence staining of PBX1 and HOXD11 in 621-101 cells. Confocal microscopy shows nuclear costaining of PBX1 and HOXD11. (F) Immunofluorescence staining of PBX1 and HOXD11 in LAM lung cells. Confocal microscopy shows nuclear costaining of PBX1 and HOXD11. (G) Genotyping PCR identified wild-type (WT) and PRCre;Tsc2f/f (Tsc2KO) mice (a). Gross examination of mouse uteri at 27 weeks of age. Arrowheads showed uterine tumors and asterisks point to uterine cysts (b). Histopathology showed uterine morphology from a Tsc2KO mouse (c). Immunoblotting analysis of Tsc2 and phosphorylated S6 (phospho-S6) (Ser235/236) in uterine tissues from WT and Tsc2KO mice at 27 weeks of age. β-Actin as a loading control (d). Immunofluorescence staining of PBX1 and HOXD11 in myometrial tumor cells from a Tsc2KO mouse. Confocal microscopy shows nuclear costaining of PBX1 and HOXD11 mouse myometrial tumor cells (e to l). Scale bars, 20 [for (E), (F), and (G, e to l)] and 50 μm [for (G, c)] and 10 mm [for (G, b)].CC BY-NC · PubMed Central
Fig. 4. TRNs analysis using paired gene expression and chromatin accessibility data. (A) LAMCORE cells transcriptional regulatory network (TRN) was constructed using PECA (top 1% of the network was displayed). LAMCORE cells scRNA-seq of four patients with LAM and snATAC-seq data from three patients with LAM were used for the network construction. The edge regulation score cutoff was 99th percentile. TF node size and font size are proportional to the number of edges connected to the given TF. Networks and connections were visualized using the Cytoscape (version 3.7.2) software package (57). (B) Identification of HOXD11-PBX1 common upstream regulators and downstream targets. (C) Enriched bioprocess and signaling pathways of the HOXD11-PBX1 network target genes. (D) Identification of PBX-STAT (signal transducer and activator of transcription) common targets. PBX1 and three edges were combined as PBX family, and STAT1 and STAT3 were combined as STAT family. (E) Enriched bioprocess and signaling pathways of the PBX-STAT common target genes. FGFR, fibroblast growth factor receptor. (F) H&E and immunohistochemical staining for smooth muscle actin (ACTA2), HOXD11, HOXA11, and (G) phospho-STAT1 (Ser727) (P-STAT1) and phospho-STAT3 (Ser727) in FFPE specimen from a LAM lung. Scale bars, 20 and 50 μm (F). (H and I) Cell death genes HAND2 and CRYAB were measured in normal control and LAM lung tissues by RT-PCR. Data are means ± SEM. **P < 0.01; ***P < 0.001, two-tailed unpaired Student’s t test.
Fig. 4. TRNs analysis using paired gene expression and chromatin accessibility data. (A) LAMCORE cells transcriptional regulatory network (TRN) was constructed using PECA (top 1% of the network was displayed). LAMCORE cells scRNA-seq of four patients with LAM and snATAC-seq data from three patients with LAM were used for the network construction. The edge regulation score cutoff was 99th percentile. TF node size and font size are proportional to the number of edges connected to the given TF. Networks and connections were visualized using the Cytoscape (version 3.7.2) software package (57). (B) Identification of HOXD11-PBX1 common upstream regulators and downstream targets. (C) Enriched bioprocess and signaling pathways of the HOXD11-PBX1 network target genes. (D) Identification of PBX-STAT (signal transducer and activator of transcription) common targets. PBX1 and three edges were combined as PBX family, and STAT1 and STAT3 were combined as STAT family. (E) Enriched bioprocess and signaling pathways of the PBX-STAT common target genes. FGFR, fibroblast growth factor receptor. (F) H&E and immunohistochemical staining for smooth muscle actin (ACTA2), HOXD11, HOXA11, and (G) phospho-STAT1 (Ser727) (P-STAT1) and phospho-STAT3 (Ser727) in FFPE specimen from a LAM lung. Scale bars, 20 and 50 μm (F). (H and I) Cell death genes HAND2 and CRYAB were measured in normal control and LAM lung tissues by RT-PCR. Data are means ± SEM. **P < 0.01; ***P < 0.001, two-tailed unpaired Student’s t test.CC BY-NC · PubMed Central
Fig. 5. Suppression of PBX1 inhibits STAT1/3 phosphorylation and causes the death of TSC2-null LAM-derived cells. (A) 621-101 cells were infected with lentivirus expressing two PBX1–short hairpin RNAs (shRNAs) or pLKO.1 vector. Immunoblotting analysis of PBX1, phospho-STAT1 (Ser727), STAT1, phospho-STAT3 (Ser727), STAT3, and cyclin D1; β-actin as a loading control. (B) Densitometry of protein levels from (A), normalized to β-actin. (C) Transcript levels of PBX1 and ESR1 were measured by RT-PCR in cells from (A). (D) 621-101 cells were treated with 100 μM Fludarabine for 24 and 48 hours. The transcript levels of ESR1 were measured by RT-PCR. (E) Immunoblotting analysis of TSC2. β-Actin was a loading control. (F) Viability of 621-101 and 621-103 cells (n = 6 wells per treatment) was assessed 72 hours after treatment with Fludarabine. GI50 was calculated using CompuSyn. (G) Phase-contrast microscopy showed cell morphology after 72 hours of Fludarabine treatment of 621-101 cells and 621-103 cells. Scale bars, 50 μm. (H) Crystal violet staining of 621-101 (TSC2−) and 621-103 (TSC2+) cells after 72 hours of Fludarabine treatment. Blue stain indicates live cells. (I) Crystal violet was solubilized in methanol, and absorbance was measured at 590 nm. OD590, optical density. (J) Immunoblotting analysis of 621-101 cells treated with Fludarabine for 24 or 48 hours. Protein levels of phospho-STAT1 (Ser727), phospho-STAT3 (Ser727), PBX1, and poly(adenosine 5′-diphosphate–ribose) polymerase (PARP) cleavage were assessed. β-Actin was used as a loading control. (K) Densitometry analysis of PARP 85 kDa to PARP 115 kDa from (J). Two-tailed unpaired Student’s t test was used for statistical analysis. Data are means ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, two-tailed unpaired Student’s t test.
Fig. 5. Suppression of PBX1 inhibits STAT1/3 phosphorylation and causes the death of TSC2-null LAM-derived cells. (A) 621-101 cells were infected with lentivirus expressing two PBX1–short hairpin RNAs (shRNAs) or pLKO.1 vector. Immunoblotting analysis of PBX1, phospho-STAT1 (Ser727), STAT1, phospho-STAT3 (Ser727), STAT3, and cyclin D1; β-actin as a loading control. (B) Densitometry of protein levels from (A), normalized to β-actin. (C) Transcript levels of PBX1 and ESR1 were measured by RT-PCR in cells from (A). (D) 621-101 cells were treated with 100 μM Fludarabine for 24 and 48 hours. The transcript levels of ESR1 were measured by RT-PCR. (E) Immunoblotting analysis of TSC2. β-Actin was a loading control. (F) Viability of 621-101 and 621-103 cells (n = 6 wells per treatment) was assessed 72 hours after treatment with Fludarabine. GI50 was calculated using CompuSyn. (G) Phase-contrast microscopy showed cell morphology after 72 hours of Fludarabine treatment of 621-101 cells and 621-103 cells. Scale bars, 50 μm. (H) Crystal violet staining of 621-101 (TSC2−) and 621-103 (TSC2+) cells after 72 hours of Fludarabine treatment. Blue stain indicates live cells. (I) Crystal violet was solubilized in methanol, and absorbance was measured at 590 nm. OD590, optical density. (J) Immunoblotting analysis of 621-101 cells treated with Fludarabine for 24 or 48 hours. Protein levels of phospho-STAT1 (Ser727), phospho-STAT3 (Ser727), PBX1, and poly(adenosine 5′-diphosphate–ribose) polymerase (PARP) cleavage were assessed. β-Actin was used as a loading control. (K) Densitometry analysis of PARP 85 kDa to PARP 115 kDa from (J). Two-tailed unpaired Student’s t test was used for statistical analysis. Data are means ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, two-tailed unpaired Student’s t test.CC BY-NC · PubMed Central
Fig. 6. Suppression of STAT1 does not affect lung colonization of Tsc2-null rat uterine leiomyoma–derived cells. (A) Rat uterine leiomyoma–derived ERL4 cells were treated with STAT1 inhibitor Fludarabine with 100 μM or vehicle control for 16 hours. Quantification of cellular bioluminescence intensity shows luciferase activity in treated cells. (B) Cells were collected and for protein extraction. Immunoblotting analysis of ERL4 cells after Fludarabine treatment. Protein levels of phospho-STAT1 (Ser727) and phospho-STAT3 (Ser727) were assessed. β-Actin was used as a loading control. (C) Female NSG mice were pretreated with Fludarabine (40 mg/kg ip) for 2 days and then intravenously inoculated with 2 × 105 ERL4 cells. (D and E) Bioluminescence imaging was performed to visualize and quantify bioluminescence signals from luciferase-expressing ERL4 cells. Total photon flux per second present in the chest regions were quantified in mice inoculated with luciferase-expressing cells 0, 6, 24, and 72 hours after cell inoculation (n = 4 per group).
Fig. 6. Suppression of STAT1 does not affect lung colonization of Tsc2-null rat uterine leiomyoma–derived cells. (A) Rat uterine leiomyoma–derived ERL4 cells were treated with STAT1 inhibitor Fludarabine with 100 μM or vehicle control for 16 hours. Quantification of cellular bioluminescence intensity shows luciferase activity in treated cells. (B) Cells were collected and for protein extraction. Immunoblotting analysis of ERL4 cells after Fludarabine treatment. Protein levels of phospho-STAT1 (Ser727) and phospho-STAT3 (Ser727) were assessed. β-Actin was used as a loading control. (C) Female NSG mice were pretreated with Fludarabine (40 mg/kg ip) for 2 days and then intravenously inoculated with 2 × 105 ERL4 cells. (D and E) Bioluminescence imaging was performed to visualize and quantify bioluminescence signals from luciferase-expressing ERL4 cells. Total photon flux per second present in the chest regions were quantified in mice inoculated with luciferase-expressing cells 0, 6, 24, and 72 hours after cell inoculation (n = 4 per group).CC BY-NC · PubMed Central
Fig. 7. Suppression of PBX1 delays lung colonization of TSC2-null cells. (A) LAM patient–derived TSC2-null 621-101 cells were treated with PBX1 antagonist HXR9 with indicated concentrations for 5 hours. Phase-contrast light microscopy shows cell viability after treatment. Scale bars, 50 μm. (B) Cells were stained with crystal violet. Quantification of crystal violet staining (OD: 590 nm) of 621-101 (TSC2−) and 621-103 (TSC2+) live cells after 5 hours of HXR9 treatment. *P < 0.05; ***P < 0.001; ****P < 0.0001, two-way analysis of variance (ANOVA) with multiple comparisons. (C) Immunoblotting analysis of 621-101 (TSC2−) and 621-103 (TSC2+) cells treated with HXR9 for 3 hours. Protein levels of cleaved caspase-3 and phospho-RIPK1 (Ser166) were assessed. β-Actin was used as a loading control. (D) Female NSG mice were pretreated with HXR9 [2 mg/kg intravenously (iv)] for 2 days and then intravenously inoculated with 2 × 105 ERL4 cells. (E) Bioluminescence imaging was performed to visualize and quantify bioluminescence signals from luciferase-expressing ERL4 cells. *P < 0.05, two-tailed unpaired Student’s t test. (F) 621-101 cells expressing luciferase (621L9) cells were infected with lentivirus of PBX1-shRNA cells or control pLKO.1 empty vector. Immunoblotting analysis of PBX1 and STAT3. β-Actin was used as a loading control. (G) Female NSG mice were intravenously inoculated with 621L9-shRNA-PBX1 or pLKO.1 control cells. (H) Total photon flux per second present in the chest regions were quantified in mice inoculated with luciferase-expressing cells 0, 6, and 24 hours after cell inoculation (n = 4 per group). *P < 0.05; **P < 0.01, two-tailed unpaired Student’s t test.
Fig. 7. Suppression of PBX1 delays lung colonization of TSC2-null cells. (A) LAM patient–derived TSC2-null 621-101 cells were treated with PBX1 antagonist HXR9 with indicated concentrations for 5 hours. Phase-contrast light microscopy shows cell viability after treatment. Scale bars, 50 μm. (B) Cells were stained with crystal violet. Quantification of crystal violet staining (OD: 590 nm) of 621-101 (TSC2−) and 621-103 (TSC2+) live cells after 5 hours of HXR9 treatment. *P < 0.05; ***P < 0.001; ****P < 0.0001, two-way analysis of variance (ANOVA) with multiple comparisons. (C) Immunoblotting analysis of 621-101 (TSC2−) and 621-103 (TSC2+) cells treated with HXR9 for 3 hours. Protein levels of cleaved caspase-3 and phospho-RIPK1 (Ser166) were assessed. β-Actin was used as a loading control. (D) Female NSG mice were pretreated with HXR9 [2 mg/kg intravenously (iv)] for 2 days and then intravenously inoculated with 2 × 105 ERL4 cells. (E) Bioluminescence imaging was performed to visualize and quantify bioluminescence signals from luciferase-expressing ERL4 cells. *P < 0.05, two-tailed unpaired Student’s t test. (F) 621-101 cells expressing luciferase (621L9) cells were infected with lentivirus of PBX1-shRNA cells or control pLKO.1 empty vector. Immunoblotting analysis of PBX1 and STAT3. β-Actin was used as a loading control. (G) Female NSG mice were intravenously inoculated with 621L9-shRNA-PBX1 or pLKO.1 control cells. (H) Total photon flux per second present in the chest regions were quantified in mice inoculated with luciferase-expressing cells 0, 6, and 24 hours after cell inoculation (n = 4 per group). *P < 0.05; **P < 0.01, two-tailed unpaired Student’s t test.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 61 references

Cited by

See all 16

Metadata

Authors
Olatoke, T., Wagner, A., Astrinidis, A., Zhang, E. Y., Guo, M., Zhang, A. G., Mattam, U., Kopras, E. J., Gupta, N., Smith, E. P., Karbowniczek, M., Markiewski, M. M., Wikenheiser-Brokamp, K. A., Whitsett, J. A., McCormack, F. X., Xu, Y., & Yu, J. J.
Affiliations
  • University of Cincinnati (US)
  • Cincinnati Children's Hospital Medical Center (US)
  • Texas Tech University Health Sciences Center (US)
  • Division of Pathology and Laboratory Medicine, Perinatal Institute, Division of Pulmonary Biology, Division of Pulmonary Medicine, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA.
Corresponding author
  • Olatoke, Tasnim
  • Wagner, Andrew
  • Astrinidis, Aristotelis
  • Zhang, Erik Y.
  • Xu, Yan
  • Yu, Jane J.
Venue
Science Advances
Published
2023-05-12
Volume
9
Issue
19
Pages
eadf8549-eadf8549
ISSN
2375-2548 (ISSN-L)
OpenAlex
W4376111010
Cited by
13
References
59
Citations by year
2026: 1 · 2025: 6 · 2024: 5 · 2023: 1
FWCI
2.30
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Science Advances (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Defense (W81XWH1910474, W81XWH-19-1, W81XWH, W81XWH-20)
  • Brigham and Women's Hospital
  • Cincinnati Children's Hospital Medical Center
  • National Heart, Lung, and Blood Institute (U01HL131022, R01HL138481, U01HL134745, U01HL148856, R01HL153045, R01HL160972, R01HL164414)
Topics
  • Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Medical Imaging and Pathology Studies
Keywords
lymphangioleiomyomatosis, mTORC1 hyperactivation, PBX1, Hoxd11, transcriptional regulation, cell survival, anti-apoptotic genes, STAT1/3 signaling, single-cell multi-omics, lung disease
MeSH terms
Multiomics, Animals, Female, Humans, Lung, Neoplasm Metastasis, Transcription Factors, Lymphangioleiomyomatosis, Homeodomain Proteins, Rats, Gene Regulatory Networks, Single-Cell Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.